Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT).
Hideomi YamauchiAkira BabaNobuhiro OginoSatoshi MatsushimaHirokazu AshidaMasato NagaokaHiroya OjiriPublished in: Auris, nasus, larynx (2024)
The tumor reduction rate calculated from MRI T2-weighted images may be a predictor of local recurrence in patients with maxillary sinus cancer treated with RADPLAT. Patients with lower reduction rates may benefit from early salvage surgeries.
Keyphrases
- magnetic resonance imaging
- contrast enhanced
- high dose
- low dose
- papillary thyroid
- early stage
- computed tomography
- magnetic resonance
- cone beam computed tomography
- deep learning
- diffusion weighted imaging
- radiation therapy
- optical coherence tomography
- stem cell transplantation
- locally advanced
- convolutional neural network
- type diabetes
- free survival
- young adults
- replacement therapy
- glycemic control